OSU-CHS researcher to study effects of lipoic acid on terminal liver disease
Thu, Jan 07, 2016
Martin Banschbach, Ph.D., professor of biochemistry at Oklahoma State University Center for Health Sciences, wants to find out whether injections of a natural antioxidant improve liver function in patients diagnosed with terminal liver disease.
OSU-CHS